@misc{indiciaef16ce5287888,
  title = {The mRNA-LNP platform's lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory},
  author = {Ndeupen, S. and Qin, Z. and Jacobsen, S. and Gibb, M. and Estanbouli, H. and Bouteau, A. and Cardenas, J. and Uthra, B. and Wang, Y. and Gu, J. and Igyarto, B. Z.},
  year = {2021},
  doi = {10.1101/2021.03.04.430128},
  url = {https://www.biorxiv.org/content/10.1101/2021.03.04.430128v1},
  note = {Source identifier: 10.1101/2021.03.04.430128}
}